Ligand Pharmaceuticals (LGND) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Ligand Pharmaceuticals (LGND) over the last 15 years, with Q3 2025 value amounting to 0.21.
- Ligand Pharmaceuticals' Asset Utilization Ratio rose 2377.26% to 0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21, marking a year-over-year increase of 2377.26%. This contributed to the annual value of 0.19 for FY2024, which is 1409.27% up from last year.
- As of Q3 2025, Ligand Pharmaceuticals' Asset Utilization Ratio stood at 0.21, which was up 2377.26% from 0.2 recorded in Q2 2025.
- Ligand Pharmaceuticals' Asset Utilization Ratio's 5-year high stood at 0.26 during Q1 2023, with a 5-year trough of 0.14 in Q1 2024.
- Its 5-year average for Asset Utilization Ratio is 0.19, with a median of 0.19 in 2022.
- In the last 5 years, Ligand Pharmaceuticals' Asset Utilization Ratio skyrocketed by 8335.17% in 2021 and then plummeted by 4626.81% in 2024.
- Over the past 5 years, Ligand Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.19 in 2021, then grew by 15.21% to 0.22 in 2022, then fell by 22.05% to 0.17 in 2023, then rose by 4.45% to 0.18 in 2024, then grew by 17.55% to 0.21 in 2025.
- Its last three reported values are 0.21 in Q3 2025, 0.2 for Q2 2025, and 0.2 during Q1 2025.